Myokines and Biomarkers of Frailty in Older Inpatients with Undernutrition: A Prospective Study - 21/11/24

Doi : 10.14283/jfa.2024.9 
Hongpeng Liu 1, , W. Li 2, M. Zhu 3, X. Wen 4, J. Jin 5, H. Wang 6, D. Lv 7, S. Zhao 8, Xinjuan Wu 9, , J. Jiao 10
1 School of Nursing, Peking University, 100191, Beijing, China 
2 Department of Clinical Nutrition, Chinese Academy of Medical Sciences - Peking Union Medical College, Peking Union Medical College Hospital (Dongdan campus), 100730, Beijing, China 
3 Department of Geriatrics, Chinese Academy of Medical Sciences - Peking Union Medical College, Peking Union Medical College Hospital (Dongdan campus), 100730, Beijing, China 
4 Department of Nursing, Sichuan Provincial People's Hospital, 610072, Chengdu, China 
5 Department of Nursing, The Second Affiliated Hospital Zhejiang University School of Medicine, 310009, Hangzhou, China 
6 Department of Nursing, Tongji Hospital, Tongji medical college, Huazhong University of Science and Technology, 430074, Wuhan, China 
7 Department of Nursing, The Second Affiliated Hospital of Haerbin medical University, 150081, Haerbin, China 
8 Department of Nursing, Qinghai Provincial People's Hospital, 810007, Xining, China 
9 Chinese Nursing Association, 100035, Beijing, China 
10 Department of Nursing, Chinese Academy of Medical Sciences - Peking Union Medical College, Peking Union Medical College Hospital, Dongdan campus, 100730, Beijing, China 

j wuxinjuan@sina.com wuxinjuan@sina.com a liuhongpeng12@sina.com liuhongpeng12@sina.com

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

Population aging might increase the prevalence of undernutrition in older people, which increases the risk of frailty. Numerous studies have indicated that myokines are released by skeletal myocytes in response to muscular contractions and might be associated with frailty. This study aimed to evaluate whether myokines are biomarkers of frailty in older inpatients with undernutrition.

Methods

The frailty biomarkers were extracted from the Gene Expression Omnibus and Genecards datasets. Relevant myokines and health-related variables were assessed in 55 inpatients aged ≥ 65 years from the Peking Union Medical College Hospital prospective longitudinal frailty study. Serum was prepared for enzyme-linked immunosorbent assay using the appropriate kits. Correlations between biomarkers and frailty status were calculated by Spearman's correlation analysis. Multiple linear regression was performed to investigate the association between factors and frailty scores.

Results

The prevalence of frailty was 13.21%. The bioinformatics analysis indicated that leptin, adenosine 5′-monophosphate-activated protein kinase (AMPK), irisin, decorin, and myostatin were potential biomarkers of frailty. The frailty group had significantly higher concentrations of leptin, AMPK, and MSTN than the robust group (p < 0.05). AMPK was significantly positively correlated with frailty (p < 0.05). The pre-frailty and frailty groups had significantly lower concentrations of irisin than the robust group (p < 0.05), whereas the DCN concentration did not differ among the groups. Multiple linear regression suggested that the 15 factors influencing the coefficients of association, the top 50% were the ADL score, MNA-SF score, serum albumin concentration, urination function, hearing function, leptin concentration, GDS-15 score, and MSTN concentration.

Conclusions

Proinflammatory myokines, particularly leptin, myostatin, and AMPK, negatively affect muscle mass and strength in older adults. ADL and nutritional status play major roles in the development of frailty. Our results confirm that identification of frailty relies upon clinical variables, myokine concentrations, and functional parameters, which might enable the identification and monitoring of frailty.

Le texte complet de cet article est disponible en PDF.

Key words : Frailty, myokines, biomarkers, skeletal muscle, undernutrition


Plan


 Trial registration: Chinese Clinical Trial Registry (ChiCTR1800017682, August 9, 2018; ChiCTR2100044148, March 11, 2021).
Contributed equally.
Electronic Supplementary Material
Supplementary material is available for this article at jfa.2024.9 and is accessible for authorized users.


© 2024  THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 13 - N° 2

P. 82-90 - février 2024 Retour au numéro
Article précédent Article précédent
  • Associations Between Hypertension, Angiotensin-Converting Enzyme Inhibitors, and Physical Performance in Very Old Adults: Results from the ilSIRENTE Study
  • Helio José Coelho-Junior, R. Calvani, M. Tosato, A. Álvarez-Bustos, F. Landi, A. Picca, Emanuele Marzetti
| Article suivant Article suivant
  • Co-Occurrence of Sarcopenia and Frailty in Acutely Admitted Older Medical Patients: Results from the Copenhagen PROTECT Study
  • Hanne Nygaard, R.S. Kamper, A. Ekmann, S.K. Hansen, P. Hansen, M. Schultz, J. Rasmussen, E. Pressel, C. Suetta

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.